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Mycobacterium tuberculosis (M.tb) and HIV are individually responsible for the most 
deaths worldwide among all infectious agents, and coinfection with M.tb and HIV 
is a significant public health challenge in the developing world. Although the lung is 
the primary target organ for tuberculosis (TB), M.tb can also cause extrapulmonary 
tuberculosis (EPTB) such as in the bones and joints. Treatment of EPTB is much more 
challenging than treatment of pulmonary TB. The hallmark of the host immune response 
against TB is the formation of organized structures called granulomas that are infiltrated 
with immune cells and are rich in cytokines and chemokines. Inside granulomas, the 
host confines the M.tb bacteria to a particular region of the organ and avoids dispersion. 
In this study, we analyzed immune cells in bone granulomas of patients with EPTB that 
are also coinfected with HIV. We found that HIV-infected TB patients have dispersed 
bone granulomas, with reduced T cell numbers and a concomitant increase in plasma 
cells. Additionally, HIV-infected patients exhibited dramatically increased serum levels of 
IgM and IgG1 antibodies, which is indicative of T-cell-independent B-cell activation and 
mucosal T-cell activation, respectively. Interestingly, we also observed that CD29+ stem 
cells are increased in HIV–TB coinfection, suggesting a link with HIV infection. Therefore, 
our work provides new insights into the architecture of spinal TB granulomas and the 
role of B-cells and humoral immunity against a highly infectious intracellular pathogen. 
We propose that our findings will inform biomarker identification for EPTB and possibly 
the development of related therapeutics and/or vaccines to protect HIV-infected patients 
against disseminated TB.
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inTrODUcTiOn
Despite recent advances in diagnosis and treatment, Mycobacterium tuberculosis (M.tb) poses a 
significant global public health threat (1). Only 10% of all individuals exposed to this pathogen 
develop active disease immediately and the remaining individuals either confine or eradicate the 
pathogen, depending on their immune status. The hallmark of the host immune response against 
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tuberculosis (TB) is the formation of an organized structure 
called a granuloma that is infiltrated with immune cells and is rich 
in cytokines and chemokines (1). Immune compromised hosts, 
however, are unable to mount an effective immune response and, 
therefore, develop active disease, progressing rapidly to severe 
morbidity and even mortality.
The most common cause of immune perturbation in M.tb-
infected individuals is HIV coinfection (2). Both TB and HIV 
have profound effects on the immune system, as they are capable 
of disarming the host’s immune defenses through mechanisms 
that are not fully understood. HIV coinfection is the most signifi-
cant known risk factor for progression of M.tb infection to active 
disease, increasing the risk of reactivation of latent TB by 20-fold 
(3). TB has also been reported to exacerbate HIV infection (4). 
In South Africa, 76% of all TB cases registered in 2014 were HIV 
coinfected and on treatment with combination antiretroviral 
therapy (cART) (5). Acute HIV-1 infection is characterized 
by extremely high viremia, which the host immune system is 
subsequently able to partially control to a stable set point. Acute 
viremia is accompanied by a precipitous drop in tissue and cir-
culating CD4+ T cells, a cytokine storm that never fully resolves, 
and generalized immune activation that has been associated with 
detrimental clinical outcome (6). Together, HIV and TB coinfec-
tion lead to rapid CD4+ T cell depletion (7), high viral load, and 
uncontrolled immune activation that exacerbates progression 
to end-stage AIDS. The large-scale application of cART has 
improved the quality of life of HIV-1-infected individuals and has 
reduced the incidence of active TB. Despite these public health 
gains, individuals on cART may still develop active TB at differ-
ent stages of HIV infection (8), highlighting the need to better 
understand the underlying mechanisms of disease pathogenesis 
in coinfected individuals to facilitate better clinical management 
and disease prevention.
One of the more severe yet rare forms of TB is spinal TB, also 
known as Pott’s disease (9). In this condition, M.tb infiltrates via 
hematogenous spread from a pulmonary source (either active or 
latent) the spinal column where vertebrae, intervertebral disks 
and extradural tissue become infected with the formation of a 
“cold” abscess around the lesion (9). Recent reports have sug-
gested that certain strains of M.tb exhibit enhanced affinity for 
osteoblasts (10). The vast majority of cases present with localized 
paraspinal infection without dissemination to the meninges 
(11). In extreme cases, paralysis may ensue as a result of spinal 
cord compression and loss of innervation. The disease normally 
resolves with anti-TB chemotherapy but surgical intervention 
involving wound debridement and insertion of a stabilizing 
bone graft (6) is necessary in severe cases (9). We previously 
described the cellular composition of spinal TB granulomas in 
HIV-infected patients, which resembled those of pulmonary 
TB granulomas in HIV-uninfected patients despite some subtle 
differences (12). In coinfected patients, spinal granulomas 
lacked organization and structure, CD4+ T-cell infiltration was 
restricted, and cellular composition was altered. In both HIV-
infected and -uninfected individuals, immune cell populations 
included macrophages (CD68+), multinucleated giant cells, and 
CD3+, CD4+, and CD8+ T-cells. Nevertheless, little is known 
regarding the spectrum of immune cells involved and their exact 
contribution to TB immune responses in the spinal cord. The role 
of B-cells, plasma cells, epithelioid cells, and mesenchymal stem 
cells (MSCs), which have been characterized in pulmonary TB, 
have yet to be explored in spinal TB. Examination of the humoral 
arm of the anti-TB immune response has revealed that detection 
of anti-AG85 IgG antibodies is associated with favorable clinical 
outcomes in Mexican-American populations with pulmonary 
TB (13). Similarly, animal studies have demonstrated protective 
responses in mice inoculated with M.tb-specific IgG antibodies 
(14) and reduced disease severity in mice inoculated with M.tb-
specific IgA antibodies (15).
In this study, we aimed to advance our understanding of the 
site-specific immune response within the discrete abscess of the 
spine by investigating the role of cell types such as B-cells, plasma 
cells, and MSCs in the immune response against TB. Furthermore, 
we sought to explore the possible implications of immune cell 
trafficking to the site of infection on the HIV immune response. 
Finally, we wanted to determine what, if any role the humoral 
immune response has at the site of spinal TB infection and how it 
may relate to the hypergammaglobulinemia associated with HIV 
infection.
MaTerials anD MeThODs
Patient study cohort
Study participants were recruited from the Spinal Unit, King 
George V Hospital (now King Dinuzulu Hospital), Durban, 
South Africa between 2002 and 2003. This is a specialized referral 
within a public hospital that manages complex, often unresolved 
spinal pathologies including trauma and infections. Details of 
the unit and the cohort are provided elsewhere (12). Briefly, 
patients with clinical symptoms and radiological signs of spinal 
TB and who had not resolved their pathology despite anti-TB 
treatment for 5–24 weeks were recruited into the study. Patients 
with pulmonary TB, immunosuppressive disorders (other than 
HIV), and those on chronic steroids for clinical management of 
congenital disorders were excluded from the study. Radiological 
suspicion of spinal TB was confirmed with MRI scans, which also 
directed surgical debridement and graft insertion to the specific 
site of infection.
All participants in the study provided written informed con-
sent. For children, consent was obtained from their parent(s) or 
guardian(s). The Biomedical Research Ethics Committee of the 
University of KwaZulu-Natal approved the study (H112/02).
sample collection and Diagnostic Tests
To investigate the pathology and cellular architecture of 
granulomatous regions in the spine of patients, we used tissue 
fragments, excised during surgery from regions close to the 
vertebrae and proximate to the dura of the spinal cord, for histo-
logical analysis. The precise location of biopsies used to prepare 
the formalin-fixed paraffin-embedded (FFPEs) relative to the 
spinal cord and vertebrae was determined using X-ray images 
and MRI scans of the infected area. Abscess wall biopsies were 
collected from tissue proximate to the areas of bone destruction 
and vertebrae, usually anteriorly and close to the spinal cord. 
Biopsies were also harvested from abscesses surrounding the 
TaBle 2 | Antibodies used for identification of distinct immune cell types.
antibodies cell types stained clone
CD3 T cells Similar to F7.2.38
CD68 Monocyte/macrophage PG-M1
Pax5 Pro B to mature B cells DAK-Pax5
CD138 Plasma B cells MI15
CD29 Mesenchymal stem cells B3B11
p24 HIV protein Kal-1
TaBle 1 | Clinical and demographic data of the patient cohort.
Parameter hiV negative (n = 12) hiV positive (n = 14)
Mean age ± SD (years) 35.8 ± 22.0 28.7 ± 15.7
Range 2.00–71.00 2.00–65.00
Gender
Male (%) 4 (30.77) 5 (31.25)
Female (%) 9 (69.23) 11 (68.75)
Mean absolute CD4 
count ± SD (cells/μl)
869.94 ± 549.48 544.24 ± 388.50
Range 319.00–2,254.20 74.47–1,080.50
Mean percentage CD4 
count ± SD (%)
43.36 ± 15.97a 23.58 ± 10.27a
Range 24.86–72.00 8.82–43.00
Mean absolute CD8 
count ± SD (cells/μl)
870.57 ± 710.53 1,098.09 ± 739.79
Range 194.00–1,269.00 26.99–2,512.00
Mean percentage CD8 
counts ± SD (%)
37.46 ± 10.00a 57.39 ± 12.82a
Range 26.84–59.00 30.00–84.00
CD4:CD8 ratio 1.25 ± 0.56 3.63 ± 12.02
Range 0.55–2.23 0.10–45.39
Mean viral load ± SD (log 
copies/ml plasma)
4.57 ± 0.93
Range 2.92–6.39
aDenotes the statistical significance.
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vertebrae with bone and disk destruction and involvement. 
A detailed description with related X-ray images is presented in 
Danaviah et al. (12).
Granulomatous tissue was collected during surgical removal 
of diseased bone, tissue, and the psoas abscess formed by the 
M.tb infection around the spinal column. Whole blood (EDTA 
anticoagulant) was also collected at surgery from each patient. 
Blood samples were submitted for T-cell quantification (CD4 
and CD8 absolute and percentage counts) as well as for HIV 
serological diagnosis (Organon Teknika Vironostika and 
confirmatory Murex Wellcozyme HIV1+2 GAC assay). Plasma 
viral loads were performed on all samples that were serologi-
cally positive using the NucliSens™ QT kit, Organon-Teknika 
(Table 1).
sample Processing
Tissue was placed in formalin (4% formaldehyde + 0.9% NaCl, 
1:8 v/v) within 1 h of collection, and using conventional protocols, 
was processed and embedded in paraffin wax to produce (FFPE) 
blocks. Serial ultra-thin sections (5 µm thickness) were cut from 
each block for hematoxylin and eosin (H&E) staining (first sec-
tion) and immune-localization studies (subsequent sections).
immune-localization studies
Specimens were selected based on H&E staining, with samples 
displaying intact granulomas chosen for the current study. 
Different cell subsets localized in the granuloma were identified 
using antibodies directed against standard cell-type specific 
markers (Table 2). The number of positively stained cells for a 
particular antibody in a selected region of interest (ROI) (at the 
same magnification) was quantified, manually, for all the samples 
by the same investigator (Debapriya Bhattacharya). The nuclei 
of stained and unstained cells were counted to determine the 
absolute number of cells per ROI.
Immunocytochemistry was performed using the Envision 
TM Flex mini kit according to the manufacturer’s standard 
protocols. Briefly, the procedure involved de-paraffinization of 
sections with xylene, followed by hydration in graded ethanol 
and unblocking of antigen sites by incubation of sections in 
retrieval buffer at medium to high temperature in a microwave 
as per the manufacturer’s protocol (Envision TM Flex mini kit; 
Code K8023, Dako, Denmark). The peroxidase blocker of the 
kit was then used to block endogenous peroxidase activity, fol-
lowed by incubation of sections with the primary antibody for 
20  min. Next, samples were incubated with HRP-conjugated 
secondary antibodies for 40 min followed by visualization with 
the DAB (3,3′Diaminobenzidinetetrahydrochloride) chromogen 
and nuclear visualization using Mayer’s Hematoxylin (Biocare 
Medical, CA, USA).
For double staining of HIV protein p24 and CD68 or CD3, we 
used the Envision TM G/2 Double stain system. The procedure is 
similar to the single stain procedure up to incubation of retrieval 
buffer; after that, the sections were treated with dual endogenous 
enzyme blocker followed by incubation with the primary p24 
antibody for 30  min. The section was then incubated with the 
secondary antibody anti-mouse or anti-rabbit IgG for 30  min 
followed by incubation with polymer HRP. Sections were then 
washed and incubated for color development using DAB solu-
tion. Subsequently, sections were re-incubated in double stain 
blocker followed by incubation with second primary antibody 
(either CD68 or CD3) and then incubated with linker followed 
by Polymer AP and colored by permanent red working solution 
(Envision double staining kit, Dako). The sections were then 
washed with distilled water followed by hematoxylin staining of 
the nucleus.
immunoglobulin Quantification
Immunoglobulin (Ig) M, total IgG, and the isotypes IgG1, IgG2, 
IgG3, and IgG4 from the serum of patients were assayed by a 
Luminex microbead-based multiplexed assay using commer-
cially available kits according to the manufacturer’s instructions 
(Bioplexpro™ Human isotyping panel, 6 Plex, Bio-Rad).
statistical analysis
Data were analyzed in Stata V11 and SPSS. Given the small sample 
size of our cohort, we used non-parametric tests as well as Tukey’s 
one-way ANOVA of significance and correlation where a 5% level 
of significance was accepted as demonstrating differences and 
FigUre 1 | Cellular architecture of spinal tuberculosis (TB) granulomas. [(a), i,ii] Images show a representative area of a granuloma stained with H&E. (B) 
Distribution of CD68+ cells within spinal TB granulomas of HIV− and HIV+ patients. [(B), ai,aii]: 20× and [(B), bi,bii]: 40× microscopic view of anti-CD68 stained cells; 
[(B), ci,cii]: hematoxylin and eosine stained giant cells. (c) Pooled absolute numbers of CD68+ cells in different specimens of HIV+ and HIV− samples. (D) Distribution 
of CD3+ cells. [(D), ai,aii]: 20× and [(D), bi,bii]: 40× microscopic view of anti-CD3 stained cells; (e) pooled absolute numbers of CD3+ cells in different samples  
(*denotes the statistical significance).
4
Bhattacharya et al. Cellular Architecture of Spinal-TB Granuloma
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1120
associations, respectively. Graphs illustrating these relationships 
were also generated in Stata V11.
resUlTs
clinical and Demographic Data of the 
Patient cohort
Previously, it has been demonstrated that various immunocytes 
infiltrate within spinal granulomas of HIV-1-uninfected and 
-infected TB patients (12), but the role of these cells in disease 
pathogenesis remains largely unknown. Furthermore, we 
hypothesized that MSCs may play a role in Pott’s disease, as these 
cells were recently shown to contribute to suppressed immune 
responses in a mouse model of pulmonary TB (16). Based on 
availability of FFPE blocks, we selected 30 patients, including 12 
HIV-uninfected and 14 HIV-infected individuals with a mean 
age of 35.8 ± 22.0 and 28.7 ± 15.7 years, respectively (Table 1). As 
previously reported, most of the participants in our cohort were 
females (Table 1). Absolute CD4 counts in HIV-infected patients 
were not significantly different to those of HIV-uninfected 
patients. However, the percentage of CD4 cells was significantly 
decreased in HIV-positive patients (Table 1; p < 0.01). In con-
trast, while the absolute CD8+ counts where similar between 
the two groups, the percentage of CD8 cells was significantly 
higher in HIV-positive patients (Table 1; p < 0.01). Viral loads 
in the HIV-infected group were high (average =  4.57 ±  0.93 
log10 copies/ml; range = 2.92–6.39 log10 copies/ml) and none of 
the patients presented with viral suppression since they were not 
on cART at the time of sample collection.
architecture and immune cell content of 
granulomas
Serial sections were assayed as follows. The first section was 
stained with H&E and the remaining sections were used to local-
ize the cells stained by antibodies against CD68, CD3, CD138, 
CD29, Pax5, CD68 with p24, and CD3 with p24 (Table  2). 
In order to analyze immune-localization of various cell types 
in the two groups, we manually counted cell numbers within 
regions of interest. Histologic examination of low-power images 
of H&E-stained tissue revealed the classic structure of a typical 
granuloma in the HIV-uninfected specimens (Figure  1A, i). 
However, a more diffuse or heterogeneous structure was typical 
FigUre 2 | Plasma B cells and mesenchymal stem cells are increased dramatically during HIV-tuberculosis (TB) coinfection. (a) Distribution and percentage of 
Pax5+ cells within spinal TB granulomas. [(a), ai,aii]: 20× and [(a), bi,bii]: 40× microscopic view of Pax5-stained cells; (B) pooled absolute number of Pax5+ cells in 
different samples. (c) Distribution and percentage of CD138+ plasma-B cells within spinal TB granulomas. [(c), ai,aii]: 20× and [(c), bi,bii]: 40× microscopic view of 
CD138+ stained cells; (D) Pooled absolute numbers of CD138+ cells in different samples. (e) Percentage of CD29+ cells within spinal TB granulomas of HIV-negative 
and -positive patients. [(e), i,ii]: 40× microscopic view of anti-CD3 stained cells; (F) pooled absolute number of CD29+ cells in different samples. (g) CD4+ T cells 
and CD68+ macrophages are a reservoir of HIV. [(g), i,ii]: 40× microscopic view of CD3+ or CD68+ cells double-stained for localization of HIV protein p24; pink is 
stained for either CD3+ or CD68+ cells, brown is for p24 protein of HIV, and brownish pink color is for double staining. (h) Pooled absolute number of double-stained 
cells in different samples (*denotes the statistical significance).
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of HIV-infected tissue (Figure 1A, ii). Both groups displayed the 
presence of macrophages and T-cells in H&E-stained sections 
as well as in immune-localized stained tissue (Figures 1A,B,D). 
We noted the presence of CD68+ monocytes and multinucle-
ated giant cells in both HIV-uninfected (Figure  1B, ai,bi,ci) 
and -infected tissues (Figure 1B, aii,bii,cii). The distribution of 
macrophages was more contained within the granulomas in the 
HIV-uninfected samples, but diffuse in the HIV-infected sam-
ples. Multinucleated giant cells displayed the same morphology 
in both groups (Figure 1B, ci,cii) and absolute numbers of CD68+ 
cells were not significantly different between HIV-infected and 
-uninfected tissue (p = 0.36) (Figure 1C). Similarly, T-cell dis-
tribution as demonstrated by anti-CD3 antibody staining was 
confined largely to the periphery with specific staining within 
the granuloma in HIV-uninfected specimens (Figure 1D, ai,bi). 
HIV-infected tissue again displayed diffuse staining where 
CD3+ T  cells were scattered throughout the granulomatous 
region (Figure 1D, aii,bii). We also noted that total numbers of 
CD3+ cells were higher in HIV-uninfected compared with HIV-
infected specimens (p = 0.03) (Figure 1E).
Next, we analyzed immature B cells and plasma cells within 
the spinal granulomas. We first used an antibody to Pax5, a 
master transcription factor of the B cell lineage expressed in pre-
cursor B cells up to mature B cells. In both HIV-uninfected and 
coinfected tissue, we noted the presence of Pax5-positive B cells 
diffusely distributed within the tissues, but not within the center 
of granulomas (Figure 2A). We extended our analysis by includ-
ing anti-CD138 antibodies, which stain terminal plasma cells. A 
notable difference in the level of staining was observed with the 
HIV-infected specimens showing diffuse positive staining over 
large portions of tissue (Figure 2C, aii,bii), whereas in contrast, 
HIV-uninfected tissue displayed limited staining (Figure  2C, 
ai,bi). In both groups, plasma cells were observed at the periph-
ery of granulomas. When we enumerated the absolute numbers 
of Pax5+ and CD138+ cells, we found a significant increase in 
CD138+ plasma cells (Figure  2D; p  =  0.01) in HIV-infected 
FigUre 3 | IgM and IgG serum levels are altered during HIV-tuberculosis 
(TB) coinfection. Graphical representation of immunoglobulin expression 
levels measured in control samples that were HIV- and TB-negative (blue); 
spinal TB-positive but HIV-negative (salmon); spinal TB-positive and 
HIV-positive (green). (a) Total serum IgM. (B) Total serum IgG (*denotes the 
statistical significance).
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compared with -uninfected tissue, whereas no difference was 
observed in the numbers of Pax5+ B cells (Figure 2B; p = 0.49).
Mesenchymal stem cells were identified by immunolocaliza-
tion of the CD29 Ab as per our previous work (16) whereas 
with the current study, only one marker was used to identify 
this immune cell subset. These cells were present in both 
HIV-negative and -positive samples (Figure  2E, i,ii). In HIV-
uninfected samples, MSCs were located in the peripheral of 
granulomas whereas in HIV-infected samples, MSCs were more 
sparsely distributed and were dispersed throughout the granu-
lomas. Interestingly, significantly increased numbers of CD29+ 
MSCs were present in the HIV coinfected compared with the 
HIV-uninfected group (p = 0.003) (Figure 2F).
Finally, to investigate the distribution of HIV-infected mac-
rophages and T-cells, we performed dual staining of anti-p24 
HIV antibody with the T-cell-specific anti-CD3 antibody or with 
the macrophage-specific anti-CD68 antibody. Both CD3+ T cells 
and CD68+ cells displayed colocalization with HIV-1 anti-p24 
antibody staining (Figure 2G, i,ii and Figure 2H).
hiV infection induces igg and/or igM 
responses
Since CD138+ plasma cells are significantly increased in HIV-
positive patients, we explored the dynamics of their activation 
and their specificity. For this purpose, we measured a surrogate 
marker of activation, total serum immunoglobulin level, since 
IgGs are mainly antigen-specific and T-cell-dependent whereas 
IgMs are mainly T-cell independent.
We noted that both IgG and IgM levels were significantly 
increased in plasma samples of the HIV-positive group 
(p =  0.003 and 0.01, respectively, by Tukey’s one-way ANOVA) 
(Figures  3A,B). In the HIV-negative group, plasma IgG and 
IgM concentrations were low and were similar to concentrations 
measured in the control samples (HIV-negative and M.tb-negative 
plasma samples) (Figures 3A,B). This suggests that the increased 
infiltration of plasma cells in HIV-positive tissue samples might 
contribute to increased activation of the humoral immune response 
in coinfected individuals. Finally, we determined IgG subtypes 
(Figure 4), which revealed that IgG1 was significantly increased in 
HIV-positive samples (p = 0.0001) whereas IgG4 was significantly 
increased in HIV-negative samples (p = 0.047) (Figures 4A,D).
DiscUssiOn
The host and pathogen in TB and HIV infection are in a fine 
balance that is influenced by a number of inter-related factors 
(17). Primary among them is the host immune response. In this 
study, we present evidence for involvement of the humoral and 
cellular arms of the immune response in spinal TB and that HIV 
coinfection significantly enhances B-cell trafficking to spinal TB 
granulomas. We further present the novel finding that coinfection 
augments MSC localization to the site of infection in granulomas. 
Similarly, total serum IgG and IgM levels were increased in coin-
fected patients, and IgG subclasses were differentially affected by 
the HIV status of the host.
In our previous study, we focused on the distribution and 
density of macrophages and T cells, mainly CD4 and CD8 cell 
populations, and compared them in spinal TB granuloma of 
HIV-infected or uninfected patients (12). However, in the present 
study, we expanded these findings to focus on B cells, plasma cells, 
and MSCs as well as investigating the humoral response by meas-
uring IgM and IgG levels. For completeness and consistency, we 
again stained macrophages and CD3-positive T cells such that we 
now gain an understanding of the relationship between and the 
activation status of T-cells, B-cells, and plasma cells in spinal TB 
of HIV-infected or uninfected patients. Also, we found that anti-
HIV p24 antibody is present in T-cells and macrophages within 
the granulomas. These findings support our hypothesis that TB 
may enhance HIV replication within T-cells and macrophages 
inside granulomas (18), which is consistent with the findings of 
other studies (4, 19–21).
While much is known about the role of T-cells in the host 
immune response against TB, the role of B-cells and the antibod-
ies they produce remain incompletely understood. A few studies 
have provided evidence for a protective role of antibodies in 
Mtb infection (22, 23). Further, B-cell localization studies using 
anti-CD20 antibody in a primate model identified positive cells 
in aggregates as well as scattered throughout the lymphocytic 
cuff of the granulomas (24). In our study, we found a peripheral 
distribution of Pax5-positive B-cells in HIV-negative TB tissue 
and a more diffuse distribution in HIV-positive TB-infected tis-
sue. The difference in distribution may be attributed to the host 
(primate versus human). Severely suppressed B-cell populations 
have previously been identified in human peripheral blood 
samples from pulmonary TB patients as compared with healthy 
controls (25). The breadth of the antigen-specific B-cell response 
FigUre 4 | IgG1 levels are increased during HIV-tuberculosis (TB) coinfection. Representative box-plots illustrating expression levels of IgG subclasses IgG1 (a), 
IgG2 (B), IgG3 (c), and IgG4 (D) in control (blue), HIV-negative (salmon), and HIV-positive (green) samples. Control samples are HIV- and TB-negative (*denotes the 
statistical significance).
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in TB patients is limited but the inflammatory response, as 
evidenced by upregulation of inflammatory cytokines, is robust 
(25). Our findings revealed limited numbers of B-cells in infected 
tissues, which was not dependent on HIV status. Whether these 
responses are antigen specific cannot be gleaned from our data 
and will require further investigation.
We found that plasma cells were substantially increased in 
HIV-infected specimens, suggesting localized B-cell matura-
tion. Similarly, high numbers of plasma cells were observed at 
the site of infection for pulmonary TB in non-human primates 
(24). The disparity between plasma cell (increased) and total 
B-cell (decreased) numbers that we observed in HIV-infected 
TB tissues was also found in the bone marrow of HIV-infected 
individuals (26). To explore consequences of increased plasma 
cells, we measured antibody responses and found increased total 
IgM and IgG, especially IgG1, in HIV-positive TB patient serum. 
Serum IgM and IgG levels in HIV-negative TB samples were very 
similar to those of healthy individuals. These findings are consist-
ent with the notion that T helper responses during chronic HIV 
infection are skewed toward Th2 type immunity (27). This also 
supports the view that HIV-1 Env-specific antibody responses 
are dominated by IgG1 (27). HIV-induced Th2 skewing of the 
immune response may contribute to its effects on TB coinfec-
tion, as protective immunity to TB requires Th1 responses (28). 
In contrast to our study, others report that IgG-antigen-secreting 
cells are significantly elevated in acutely infected individuals but 
that these cells do not impact Ab production (29–33). Additional 
studies have shown that elevations in plasma IgG levels during 
chronic HIV infection are antigen non-specific, resulting in 
partial hypergammaglobulinemia (34). More recently, it was 
reported that B  cell dysfunction impacts antibody-producing 
cells in the intestinal mucosa where cells of HIV-1-infected 
individuals display decreased capacity to switch from the produc-
tion of IgM to IgA or IgG antibodies (35). B-cell dysfunction is a 
hallmark of HIV infection and the disparity in B cell frequencies 
that we observed may, therefore, be attributed, in part, to HIV 
coinfection. Increased levels of IgG4 subtype in HIV-uninfected 
TB-positive patients may also indicate the presence of lymphad-
enopathy as a result of TB-infection alone.
We found MSCs in both HIV-infected and -uninfected 
specimens. These progenitor cells are able to differentiate into 
distinct cell types such as osteoblasts and have been used in 
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cellular therapeutics from aiding in tissue graft acceptance to 
adjuvants in TB infections (36). We have shown the presence 
of osteoblasts in HIV-infected patients in our cohort (12), 
which may have been derived from MSCs. We speculate that 
the presence of MSCs in bone tissue may benefit patients during 
post-surgery recovery, formation of new bone, and receipt of 
tissue allografts, regardless of HIV status (37). Given that MSCs 
also reduce inflammation and prevent tissue damage (38), these 
cells likely protect against exacerbated tissue and bone degenera-
tion that may lead to paralysis in the large majority of HIV/TB 
coinfected patients.
The TB vaccine BCG has been in use for almost a century but 
provides only limited to no protective immunity against adult 
pulmonary disease. Understanding the humoral arm of the TB 
immune response is likely to contribute new knowledge on the 
protective measures required against TB infection as was high-
lighted in a recent NIAID-convened discussion on Mtb immune 
evasion and vaccine development (39). Understanding the 
expansion of the innate and adaptive immune responses over the 
course of disease progression remains a bottleneck to develop-
ing suitable vaccines. While the full gamut of the Ab-mediated 
response may not be fully activated or effective during TB or TB/
HIV infection, it is undoubtedly a key aspect of disease contain-
ment of intra-cellular pathogens such as TB (40). Our findings 
add to the substantial body of work that describes the immune 
response to TB and HIV but provides more insight into the innate 
mechanisms of the immune response. In addition, we provide a 
possible impact of HIV/TB coinfection on the phenomenon of 
hypergammaglobulinemia in spinal TB. Our data suggest that 
B-cell dysfunction is a hallmark of HIV infection in TB coinfected 
patients, as is hypergammaglobulinemia.
cOnclUsiOn
The intimate association between HIV and TB necessitates efforts 
to understand the humoral and cellular arms of the immune 
response in coinfected hosts. The spinal TB granuloma provides 
a unique and isolated, yet highly reactive site of coinfection. Our 
studies demonstrate that the dynamics of immune cell trafficking 
and function greatly differ between HIV-infected and -uninfected 
hosts. We provide novel findings regarding B-cells, plasma cells, 
and MSCs at the site of spinal TB infection and show that HIV 
coinfection perturbs plasma cell and MSC trafficking. Additional 
studies are needed to fully dissect humoral immune responses 
in this coinfection model, which should be informative for the 
development of novel protective measures against TB and TB/
HIV coinfection.
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